Abstract
Purpose
The aim of this study is to determine the diagnostic performances of pleural procedures in undiagnosed exudative pleural effusions and to evaluate factors suggestive of benign or malignant pleural effusions in tertiary care centers.
Methods
This was a multicenter prospective observational study conducted between January 1 and December 31, 2018. A total of 777 patients with undiagnosed exudative pleural effusion after the initial work-up were evaluated. The results of diagnostic procedures and the patients' diagnoses were prospectively recorded. Sensitivity, specificity, and accuracy estimates with 95% confidence intervals were used to examine the performance of pleural procedures to detect malignancy.
Results
The mean age ± SD of the 777 patients was 62.0 ± 16.0 years, and 68.3% of them were male. The most common cause was malignancy (38.3%). Lung cancer was the leading cause of malignant pleural effusions (20.2%). The diagnostic sensitivity and accuracy of cytology were 59.5% and 84.3%, respectively. The diagnostic sensitivity of image-guided pleural biopsy was 86.4%. The addition of image-guided pleural biopsy to cytology increased diagnostic sensitivity to more than 90%. Thoracoscopic biopsy provided the highest diagnostic sensitivity (94.3%). The highest diagnostic sensitivity of cytology was determined in metastatic pleural effusion from breast cancer (86.7%).
Conclusion
The diagnostic performance increases considerably when cytology is combined with image-guided pleural biopsy in malignant pleural effusions. However, to avoid unnecessary interventions and complications, the development of criteria to distinguish patients with benign pleural effusions is as important as the identification of patients with malignant pleural effusions.
Similar content being viewed by others
References
Light RW (2011) Pleural effusions. Med Clin 95:1055–1070. https://doi.org/10.1016/j.mcna.2011.08.005
Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr (1972) Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 77:507–13. https://doi.org/10.7326/0003-4819-77-4-507
Arnold DT, De Fonseka D, Perry S, Morley A, Harvey JE, Medford A, Brett M, Maskell NA (2018) Investigating unilateral pleural effusions: the role of cytology. Eur Respir J 52:1801254. https://doi.org/10.1183/13993003.01254-2018
Metintas M, Ak G, Dundar E, Yildirim H, Ozkan R, Kurt E, Erginel S, Alatas F, Metintas S (2010) Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest 137:1362–1368. https://doi.org/10.1378/chest.09-0884
Porcel JM, Azzopardi M, Koegelenberg CF, Maldonado F, Rahman NM, Lee YC (2015) The diagnosis of pleural effusions. Expert Rev Respir Med 9:801–815. https://doi.org/10.1586/17476348.2015.1098535
Metintas M, Ak G, Cadirci O, Yildirim H, Dundar E, Metintas S (2012) Outcome of patients diagnosed with fibrinous pleuritis after medical thoracoscopy. Respir Med 106:1177–1183. https://doi.org/10.1016/j.rmed.2012.04.009
Janssen J, Maldonado F, Metintas M (2018) What is the significance of non-specific pleuritis? A trick question. Clin Respir J 12:2407–2410. https://doi.org/10.1111/crj.12940
Davies HE, Nicholson JE, Rahman NM, Wilkinson EM, Davies RJ, Lee YC (2010) Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 38:472–477. https://doi.org/10.1016/j.ejcts.2010.01.057
Metintas M, Ak G, Metintas S, Yildirim H, Dündar E, Rahman N (2019) Prospective study of the utility of computed tomography triage of pleural biopsy strategies in patients with pleural diseases. J Bronchology Interv Pulmonol 26:210–218. https://doi.org/10.1097/LBR.0000000000000559
Metintas M, Turkish Respiratory Society and Turkish Thoracic Society Pleural Guideline Group (2016) Göğüs Hastalıkları Uzmanları İçin Plevra Hastalıkları Tanı ve Tedavi Rehberi. Ankara, 1–41 (in Turkish)
Hooper C, Lee YC, Maskell N; BTS Pleural Guideline Group (2010) Investigation of a unilateral pleural effusion in adults: British thoracic society pleural disease guideline 2010. Thorax 65(Suppl 2):ii4-17. https://doi.org/10.1136/thx.2010.136978
Light R (2013) Pleural disease. Lippincott Williams & Wilkins, Philadelphia
Porcel JM, Esquerda A, Vives M, Bielsa S (2014) Etiology of pleural effusions: analysis of more than 3000 consecutive thoracenteses. Arch Bronconeumol 50:161–165. https://doi.org/10.1016/j.arbres.2013.11.007
Park JE, Do YW, Lee DH, Lee SY, Lim JK, Choi SH, Seo HW, Yoo SS, Lee SY, Cha SI, Park JY, Lee J, Kim CH (2020) Idiopathic pleural effusions: characteristics and discrimination from cytology-negative malignant pleural effusions. Am J Med Sci 360:236–242. https://doi.org/10.1016/j.amjms.2020.04.020
Zhang Y, Luo G, Etxeberria J, Hao Y (2021) Global patterns and trends in lung cancer incidence: a population-based study. J Thorac Oncol 16:933–944. https://doi.org/10.1016/j.jtho.2021.01.1626
Metintaş S, Batırel HF, Bayram H, Yılmaz Ü, Karadağ M, Ak G, Metintaş M (2017) Turkey national mesothelioma surveillance and environmental asbestos exposure control program. Int J Environ Res Public Health 14:1293. https://doi.org/10.3390/ijerph14111293
Romero-Candeira S, Hernández L, Romero-Brufao S, Orts D, Fernández C, Martín C (2002) Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions? Chest 122:1524–1529. https://doi.org/10.1378/chest.122.5.1524
Romero-Candeira S, Fernández C, Martín C, Sánchez-Paya J, Hernández L (2001) Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 110:681–686. https://doi.org/10.1016/s0002-9343(01)00726-4
Walker SP, Morley AJ, Stadon L, De Fonseka D, Arnold DT, Medford ARL, Maskell NA (2017) Nonmalignant pleural effusions: a prospective study of 356 consecutive unselected patients. Chest 151:1099–1105. https://doi.org/10.1016/j.chest.2016.12.014
Abd Own S, Höijer J, Hillerdahl G, Dobra K, Hjerpe A (2021) Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis. Diagn Cytopathol 49:606–614. https://doi.org/10.1002/dc.24395
Acknowledgements
The study was supported by Turkish Respiratory Society. We thank Turkish Respiratory Society Pleura Study Group and Young Academicians Group.
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Contributions
GA, CAB, BC, SB, and DK contributed to the study conception and design. GA, ANT, MUS, YS, MY, AT, PAK, SB, DK, NYD, OS, SB, ME, GK, GP, FG, UAA, SY, NO, SY, DE, BC, AZ, NDK, PM, IS and MM collected data. SM analysed data. GA wrote the first draft of the manuscript and all authors commented on previous versions of the manuscript. GA, SB, UY and MM edited the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ak, G., Metintas, S., Taskın, A.N. et al. Evaluation of Exudative Pleural Effusions: A Multicenter, Prospective, Observational Study. Lung 200, 807–815 (2022). https://doi.org/10.1007/s00408-022-00573-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-022-00573-8